Funding round
Pear Bio Series A
Pear Bio, which works in personalized cancer testing services in Natick, raised $14M in a Series A round announced on 15 May 2023, led by Octopus Ventures. 6 firms took part.
$14M
Amount raised
Not disclosed
Post-money valuation
6
Investors
1 lead
Valuation
What this round says about the price
Pear Bio did not disclose a valuation in this round. It is Pear Bio's first venture round on record, 6 years after it was founded in 2017. No later venture round is on record for Pear Bio.
Pear Bio's funding rounds
This is the only venture round on record for Pear Bio.
- Series A this round 15 May 2023, led by Octopus Ventures $14M
Investors
Who put money in
Octopus Ventures led the round with 5 other firms.
Lead investor
- backs 164 venture-backed companies new investor
Also in the round
- Hoxton Ventures backs 50 venture-backed companies new investor
- backs 12 venture-backed companies new investor
- backs 196 venture-backed companies new investor
- backs 25 venture-backed companies new investor
- backs 32 venture-backed companies new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to product development.
- Product development
Comparable rounds
How it compares
192 Series A rounds in Biotechnology within a year either side disclosed an amount; the median was $29M, and this round was 48% of the median. The closest in time, other companies' Series A rounds in Biotechnology:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Biotechnology | 23 May 2023 | $300M | not disclosed | MPM BioImpact and F2 Venture Capital |
| Biotechnology | 16 May 2023 | $100M | not disclosed | Novo Holdings |
| Biotechnology | 1 May 2023 | $75M | not disclosed | Apple Tree Partners |
| Biotechnology | 18 May 2023 | $73M | not disclosed | Hatteras Investment Partners |
| Biotechnology | 11 May 2023 | $50M | not disclosed | Recipharm |
| NewLimit Biotechnology | 16 May 2023 | $40M | not disclosed | not named |
| Biotechnology | 10 May 2023 | $30M | not disclosed | Boehringer Ingelheim Venture Fund and Roche Venture Fund |
| Biotechnology | 24 May 2023 | $17M | not disclosed | Illumina Ventures and RA Capital |
Sources
Where this comes from
Reported by 2 sources. The deal data marks this round as not yet confirmed by an official announcement. Unconfirmed
Questions
Frequently asked
How much did Pear Bio raise in its Series A round?
Pear Bio raised $14M in its Series A round, announced in May 2023.
Who led Pear Bio's Series A round?
Octopus Ventures led it, with Hoxton Ventures, Crista Galli Ventures, SOSV, Fly Ventures and Compound.
What was Pear Bio's valuation at the Series A round?
It was not disclosed.
How does it compare with other Series A rounds in Biotechnology?
192 Series A rounds in Biotechnology within a year either side disclosed an amount; the median was $29M, and this round was 48% of the median.